中国外交部促美方停止将证券监管政治化
美国总统特朗普上周五签署《外国公司问责法案》,如果外国公司连续三年未能通过美国公众公司会计监督委员会(PCAOB)审计,将被禁止在美国交易所上市。
外交部代表汪文斌在例行记者会上称,美国不顾中方监管部门与美方法定审计监管合作的积极努力,执意将含有明显歧视中国企业条款的所谓《外国公司问责任法案》签署成法,中方表示坚决反对。
汪文斌称,此举严重破坏中国企业赴美正常上市,严重扭曲美国自己一向标榜的市场经济基本准则,也剥夺了美国投资者和公众分享中国企业发展红利的机会,并会因此而削弱全球投资者对美国资本市场的信心,到头来只会损害美国资本市场的国际地位和声誉,促美方停止将证券监管政治化的错误做法。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.